Merit Medical Systems ( (MMSI) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Merit Medical Systems is experiencing a notable stock price movement due to a combination of strong financial performance and organizational changes. The company reported a promising revenue increase for 2024, with figures ranging from $1.355 billion to $1.357 billion, marking a growth of approximately 7.7% to 7.9% from the previous year. This is further supported by a constant currency revenue increase of around 8.4% to 8.6%. Positive market sentiment has been bolstered by the FDA approval of their WRAPSODY Cell-Impermeable Endoprosthesis. However, leadership changes, including the resignation of President Joseph Wright amid an investigation, are introducing uncertainty and likely affecting stock price targets.
More about Merit Medical Systems
YTD Price Performance: -0.45%
Average Trading Volume: 428,594
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $5.6B
For further insights into MMSI stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.